Tuesday, October 8, 2019

Johnson & Johnson Hit With $8 Billion Jury Verdict in Risperdal Suit by MIHIR ZAVERI and KATIE THOMAS


By MIHIR ZAVERI and KATIE THOMAS

A Philadelphia jury found that a subsidiary downplayed the risks that the anti-psychotic drug could lead to breast growth in boys.

Published: October 7, 2019 at 08:00PM

from NYT Health https://ift.tt/31YDhZP
via IFTTT



from WordPress https://ift.tt/31UQEdH
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)